The rise of Sildenafil initially fueled a boom for major pharmaceutical companies, however recent shifts present a murky picture for those considering a stake. Generic competitors are eating into earnings, and https://francesibgt326924.blogsumer.com/40086527/viagra-and-pharma-a-volatile-play